30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

More 2010 Results: Genzyme Biosurgery

GENZYME BIOSURGERY
* Synvisc and Synvisc-One $393.1MM, +19%
* 4Q10 revenue: $105.9MM, +11%